Bloggpost
2025 Life Science M&A: Is the Industry Primed for a Rebound?
After a slight dip in 2024, mergers and acquisitions (M&A) activity in the life sciences sector is expected to rebound strongly in 2025. Several factors, including pent-up demand, the state of company pipelines, and improving economic conditions, point towards a resurgence in dealmaking.